NEW YORK, June 27 - Syrrx and Cubist Pharmaceuticals have entered a deal to jointly develop potential antibiotic drugs, the companies said Tuesday.  

The deal represents the first collaboration with a pharmaceutical company for San Diego, Calif.-based Syrrx. The company currently has several other relationships to develop its technology platform for determining protein structures.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Associated Press reports that the US government wasted $341,000 on travel by former Health and Human Services Secretary Tom Price.

Women who post YouTube science videos get more critical comments and more comments about their appearance than male video hosts, the New York Times reports.

The Wall Street Journal writes that participating in genetic research brings up the specter of past research ethics lapses for some African Americans.

In PLOS this week: sequences influencing yeast prion aggregation or degradation, dengue virus genetic variants affect transmission dynamics, and more.